Amgen (AMGN) Return on Invested Capital (2009 - 2026)
Amgen's quarterly Return on Invested Capital came in at 0.0% in Q1 2026, little changed year-on-year from 0.0% in Q1 2025, and up 14.23% quarter-over-quarter from 0.0% in Q4 2025.
Amgen has reported Return on Invested Capital for 18 years, with the latest figure at 0.0% in Q1 2026.
- For the quarter ending Q1 2026, Return on Invested Capital changed 0.0% year-over-year to 0.0%; the trailing twelve-month figure through Mar 2026 stood at 0.0% (changed 0.0% YoY), and the FY2025 full-year result was 0.0%, changed 0.0% from the prior year.
- Return on Invested Capital for Q1 2026 stood at 0.0%, up from 0.0% in the prior quarter.
- The five-year high for Return on Invested Capital was 0.0% in Q2 2022, with the low at 0.0% in Q2 2024.
- Average Return on Invested Capital over 5 years is 0.0%, with a median of 0.0% recorded in 2025.
- Peak annual rise in Return on Invested Capital reached 0 bps in 2022, while the deepest fall reached 0 bps in 2022.
- Tracing AMGN's Return on Invested Capital over 5 years: stood at 0.0% in 2022, then sank by 52 bps to 0.0% in 2023, then fell by 1 bps to 0.0% in 2024, then rose by 27 bps to 0.0% in 2025, then rose by 14 bps to 0.0% in 2026.
- The last three Return on Invested Capital figures came in at 0.0% (Q1 2026), 0.0% (Q4 2025), and 0.0% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 0.00% |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 0.00% |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 0.00% |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | 0.00% |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 0.00% |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 0.00% |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | 0.00% |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | 0.00% |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00% |
| Dec 31, 2025 | 0.00% |
| Sep 30, 2025 | 0.00% |
| Jun 30, 2025 | 0.00% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | 0.00% |
| Sep 30, 2024 | 0.00% |
| Jun 30, 2024 | 0.00% |
| Mar 31, 2024 | 0.00% |
| Dec 31, 2023 | 0.00% |
| Sep 30, 2023 | 0.00% |
| Jun 30, 2023 | 0.00% |
| Mar 31, 2023 | 0.00% |
| Dec 31, 2022 | 0.00% |
| Sep 30, 2022 | 0.00% |
| Jun 30, 2022 | 0.00% |
| Mar 31, 2022 | 0.00% |
| Dec 31, 2021 | 0.00% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | 0.00% |
| Mar 31, 2021 | 0.00% |
| Dec 31, 2020 | 0.00% |
| Sep 30, 2020 | 0.00% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | 0.00% |
| Dec 31, 2019 | 0.00% |
| Sep 30, 2019 | 0.00% |
| Jun 30, 2019 | 0.00% |
| Mar 31, 2019 | 0.00% |
| Dec 31, 2018 | 0.00% |
| Sep 30, 2018 | 0.00% |
| Jun 30, 2018 | 0.00% |
| Mar 31, 2018 | 0.00% |
| Dec 31, 2017 | 0.00% |
| Sep 30, 2017 | 0.00% |
| Jun 30, 2017 | 0.00% |
| Mar 31, 2017 | 0.00% |
| Dec 31, 2016 | 0.00% |
| Sep 30, 2016 | 0.00% |
| Jun 30, 2016 | 0.00% |
| Mar 31, 2016 | 0.00% |
| Dec 31, 2015 | 0.00% |
| Sep 30, 2015 | 0.00% |
| Jun 30, 2015 | 0.00% |
| Mar 31, 2015 | 0.00% |
| Dec 31, 2014 | 0.00% |
| Sep 30, 2014 | 0.00% |
| Jun 30, 2014 | 0.00% |
| Mar 31, 2014 | 0.00% |
| Dec 31, 2013 | 0.00% |
| Sep 30, 2013 | 0.00% |
| Jun 30, 2013 | 0.00% |
| Mar 31, 2013 | 0.00% |
| Dec 31, 2012 | 0.00% |
| Dec 31, 2011 | 0.00% |
| Sep 30, 2011 | 0.00% |
| Jun 30, 2011 | 0.00% |
| Mar 31, 2011 | 0.00% |
| Dec 31, 2010 | 0.00% |
| Sep 30, 2010 | 0.00% |
| Jun 30, 2010 | 0.00% |
| Mar 31, 2010 | 0.00% |
| Dec 31, 2009 | 0.00% |
| Sep 30, 2009 | 0.00% |